Kinetic concepts in the treatment of breast cancer.
Surbone
A
A
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.
Norton
L
L
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology*; D002453:Cell Cycle; D002455:Cell Division; D003520:Cyclophosphamide / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007700:Kinetics; D008727:Methotrexate / Q000008:administration & dosage; D016296:Mutagenesis; D009154:Mutation
D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate